Очаговые образования поджелудочной железы
Об авторе
В. Г. НеустроевРоссия
Список литературы
1. Аксель Е М. Злокачественные новообразования желудочнокишечного тракта; основные статистические показатели и тенденции / Е.М. Аксель. М.И. Давыдов, Т.И. Ушакова // Современная онкология 2001 Т. 3. №4. С 141145
2. Базин И.С. Современные подходы к терапии рака поджелудочной железы / И С Базин, А.М Гарин // Рус. мед. журн 2006. -Т. 14, №6. - С. 488-494.
3. Блохин Н И. Рак поджелудочной железы и внепеченочных желчных протоков / Н.Н. Блохин, А.Б. Итин, А.А. Клименков. - М., 1982. 352 с.
4. Власов П.В. Лучевая диагностика заболеваний ПЖ / Л.В. Власов, П М Котляров//Вестн. рентгенол. - 1995. - If 5. -С. 513
5. Губергриц Н.Б. Клиническая панкреатология / Н.Б. Губергриц, Т.Н. Христич. - Донецк: ООО «Лебедь», 2000. - 416 с.
6. Данилов М.В. Хирургия поджелудочной железы / М.В, Данилов, В.Д. Федоров. - М.: Медицина, 1995. - 512 с.
7. Земляной В.П. Билиарная декомпрессия при механической желтухе опухолевого генеза / В.П. Земляной, С.Л. Непомнящая, А.К. Рыбкин // Практическая онкология. - 2004. - Т. 5, № 2. - С. 85-93.
8. Ильичева Е.А. Морфофункциональное обоснование хирургической тактики при новообразованиях поджелудочной железы и хроническом панкреатите: дис.. д-ра мед. наук / Е.А. Ильичева. - Иркутск, 2004. - 344 с.
9. Калинин А.В. Рак поджелудочной железы / А.В. Калинин // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 1999. -№ 1. - С. 78-83.
10. Клинико-инструментальная диагностика болезней органов гепатопанкреатодуоденальной зоны / Л.К. Соколов, О.Н. Минушкин, В.М. Саврасов, С.К. Терновой. - М., 1987. - 276 с.
11. Комплексная диагностика опухолей билиопанкреатодуоде-нальной зоны / Б.И. Долгушин [и др.] // Практическая онкология. - 2004. - Т. 5, № 2. - С. 77-84.
12. Кубышкин В.А. Рак поджелудочной железы / В.А. Кубышкин, B.А. Вишневский. - М.: Медпрактика-М, 2003. - 386 с.
13. Маады А.С. Обоснование применения эндоскопических способов дренирования желчных путей при злокачественных новообразованиях органов панкреатобилиарной зоны, осложненных механической желтухой: автореф. дис.. канд. мед. наук / А.С. Маады. - М., 2002. - 24 с.
14. Малярчук В.И. Билиопанкреатодуоденальный рак: монография / В.И. Малярчук, А.Е. Климов, Ю.Ф. Пауткин. - М.: Изд-во РУДН, 2006. - 444 с.
15. Медикаментозные и эндоскопические методы лечения хронического панкреатита / J.M. Lohr // Креон: Сателлит, симпоз. «Экзокринная недостаточность поджелудочной железы. Оптимальный путь коррекции». - М., 1998. - С. 3-6.
16. Орлов С.Ю. Эндоскопическая ультрасонография при заболеваниях поджелудочной железы: пособие для врачей / С.Ю. Орлов, Е.Д. Федоров. - М.: РГМУ, 2000. - С. 48.
17. Основные показатели работы лечебно-профилактических учреждений Иркутской области за 2005 год. - Иркутск, 2006. - С. 95.
18. Павловский А.В. Масляная химиоэмболизация артерий поджелудочной железы при местнораспространенном раке/А.В. Павловский // Практическая онкология. - 2004. - Т. 5, № 2. - С. 108.
19. Патютко Ю.И. Диагностика и хирургическое лечение рака поджелудочной железы / Ю.И. Патютко, А.Г. Котельников // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 1997. - № 5. - C. 67-72.
20. Патютко Ю.И. Современное хирургическое и комбинированное лечение больных экзокринным раком головки поджелудочной железы и органов периампулярной зоны / Ю.И. Патютко, А.Г. Котельников, М.Г. Абгарян // Практическая онкология. - 2004. -Т. 5, №2.-С. 94-107.
21. Роль и перспективы тотальной панкреатэктомии в лечении рака поджелудочной железы / В.А. Тарасов, Е.С. Побегалов, В.В. Ставровиецкий, М.Б. Блюм // Практическая онкология. - 2004. -Т. 5, №2.-С. 124-132.
22. Стандарты диагностики и лечения больных с заболеваниями органов пищеварения: приказ М-ва здравоохранения РФ № 125 от 17 апр. 1998 г.
23. Таразов П.Г. Регионарная химиотерапия при раке поджелудочной железы / П.Г. Таразов // Вопр. онкол. - 2003. - Т. 49, № 2. - С. 139-144.
24. Хазанов А.И. Причины смерти и смертность при заболеваниях органов пищеварения в Российской Федерации и европейских странах / А.И. Хазанов, Е.А. Джанашия, И. Н. Некрасова // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 1996. - № 1. - С. 14-19.
25. Хронический панкреатит, его течение и исходы /А.И. Хазанов, А.П. Васильев, В.Н. Спесивцев [и др.] // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 1999. - № 4. - С. 24-30.
26. Шелагуров А.А. Болезни поджелудочной железы / А.А. Шелагуров. - М.: Медицина, 1970. - С. 546.
27. Шехтер Ю.И. Результаты диагностических и лечебных пункций ряда внутренних органов под контролем КТ / Ю.И. Шехтер, А.Л. Юдин // Вестн. рентгенол. - 1990. - № 5/6. - С. 20-24.
28. Энциклопедия клинической онкологии: основные средства и методы диагностики и лечения злокачественных новообразований / Под ред. М.И. Давыдова. - М., 2004. - 1456 с.
29. A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer / S.R. Bramhall, J. Schulz, J. Nemunaitis [et al.] // Br. J. Cancer. - 2002. - N 87. -P 161-167.
30. A new method of intraoperativi cytodiagnosis for more precisely locating the occultneoplasms of the pancreas / O. Ishikawa S. Imaoka H. Ohigashi [et al.] // Surgery. - 1992. - N 111. - P. 294-300.
31. A phase I/ll trial of intratumoral endoscopic ultrasound njection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma / J.R. Hecht, R. Bedford, J.L. Abbruzzese [et al.] // Clin. Cancer Res. - 2003. - Vol. 9. - P. 555-561.
32. A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer/H. Oettle, D. Richards, R.K. Ramanathan [et al.] //Ann Oncol. - 2005. - Vol. 16. - P. 1639-1645.
33. A phase III trial on the therapy of advanced pancreatic carcinoma Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin/S. Cullinan, C.G. Moertel, H.S. Wieand [et al.]//Cancer. - 1990. - N 65. - P. 2207-2212.
34. A prospective study of EUS-guided celiac plexus neurolysis for pancreatic cancer pain / N T. Gunaratnam, AV. Sarma I D. Norton, M.J. Wiersema//Gastrointest Endosc. - 2001. - N 54. - P. 316-324.
35. A randomised, prospective, multicenter, phase III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resected pancreatic cancer / P. Neuhaus, H. Oettle, S. Post [et al. ] //J. Clin. Oncol. - 2005. - N 23, 16S. - P. 4013.
36. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer / J.P Neoptolemos, D.D. Stocken, H. Friess [et al. ] // N. Engl. J. Med. - 2004 N 350 - P 1200-1210
37. A study of 122 cases of pancreatic cancer diagnosed by endoscopic retrograde cholangiopancreatography (ERCP) / Y.M Moon, W.A Kim, S.T. Shin [et al. ] // Korean J.Intern Med. 1986. N 1. -P. 131-139.
38. Abdominal US for diagnosis of pancreatic tumor: prospective cohort analysis/ В M. Karlson, A Ekbom, PG. Lindgren // Radiology. 1999. N213.-P. 107-111.
39. Acute extraluminal hemorrhage associated with EUS-guided fine needle aspiration: Frequency and clinical significance / Aboud Affi. Enrique Vazquez-Sequeiros, Ian D. Norton [et al. ] // Gastrointestinal Endoscopy. - 2001. - Vol. 53, N 2. - R 57-68
40. Adenocarcinoma of the pancreatic duct: comparativeevaluation with CTand MR imaging at 1.5T/AD. Vellet, W. Romano, D.B. Bach [et al.] // Radiology. - 1992. - N 183. - P. 87-95.
41. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging / M. Kayahara T. Nagakawa K. Ueno[etal.]//Cancer. 1993. - N 72 - P. 2118-2123
42. Anderson М. CT of pancreatitis / M. Aiderson, J Me Gahan //The Radiologist. - 1994. - Vol. 1. - R 275-283.
43. Arcidiacono P.G. Endoscopic ultrasonography: impact in diagnosis, staging and management of pancreatic tumors. At overview / P.G. Arcidiacono, S. Carrara //J. Pancreas (Online). - 2004. - N 5,4. - P. 247-252.
44. Aspects of percutaneous fineneedle aspiration biopsy in the diagnosis of pancreatic carcinoma / S. Linder, M. Blasjo, P. Sundelin [etal.]//Am J. Surg. - 1997.-N 3, Vol. 174. - P. 30-36.
45. Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy / S.P. Povoski, M.S. Karpeh, K.C. Conlon [et al] //Ann. Surg. - 1999. - Vol. 230, N 2. -P. 131-142.
46. Bhutani Manoop, S. Endoscopic ultrasound in pancreatic diseases. Indications, limitations, and the future / S. Bhutani Manoop //Gastroenterology clinics. - 1999. - Vol. 28, N 3. - P. 113-125
47. Bhutani M.S. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine needle aspiration for diagnosis of malignant lymph nodes invasion / M.S. Bhutani, R.H. Hawes, B.J. Hoffman //Gastrointest Endosc. - 1997. -N 45. - P. 474-479.
48. Bhutani, M.S.Interventional Endoscopic Ultrasonography / M.S. Bhutani // Endoscopy. - 2000. - N 32. - P. 62-71.
49. Biologic and clinical significance of lymphadenectomy / J.E. Jr Gervasoni, C. Taneja M.A Chung, B. Cady // Surg. Clin. North Am. - 2000. - N80. - P. 1631-1673.
50. Bolender, R.P. Stereological analysis of guinea pig pancreas. I. Analytical model and quantitative description of non-stimulated pancreatic exocrine cells / R.P. Bolender// J. Cell. Biol. - 1974. -N61. - P. 269-287.
51. Brugge W.R. Pancreatic fine needle aspiration: To do or not to do? / R.W. Brugge // J. Pancreas (Online). - 2004. - Vol. 5, N 4. -P 282-288.
52. Brugge W.R. Pancreatic cancer staging. Endoscopic sonography criteria for vascular invasion/W.R. Brugge//Gastrointest. Clin. N. Am. - 1995.-Vol. 5, N4.-P. 741-753. '
53. Brush cytology for pancreatic carcinoma: an analysis of factors influencing results / D.E. McGuire, R.P. Venu, R.D. Brown [et al.] //Gastrointest. Endosc. - 1996. - N 44. - P. 300-304.
54. Camp E.R. Whipple resections for periampullary and pancreatic lesions/E.R. Camp, S B. Vogel [et al.] //Am. Surg. - 2004. - Vol. 70, N'1. - P. 610.
55. Caraceni A Pain management in patients with pancreatic carcinoma / A Caraceni. R.K.'Portenoy // Cancer. - 1996. - N 78, Suppl 3 P 639-653
56. Carcinoma of the pancreatic head and periampullary region. Tumor staging with laparoscopy and laparoscopic ultrasonography / T.G. John. J.D. Greig, D.C. Carter, O.J. Garden //Ann. Surg. - 1995. N221 P 156-164
57. Chemoradiation for ductal pancreatic carcinoma: principles of combining chemotherapy with radiation, definition of target volume and radiation dose / R. Wilkowski, M. Thoma H. Weingandt [et al.] // J Pancreas (Online). - 2005. Vol. 6, N 2. - P 216-230.
58. Chemotherapy prolongs survival in inoperable pancreatic carcinoma / K. Palmer, M. Kerr, G. Knowles [et al.] // Br. J. Surg. -1994 -N81-P 882-885
59. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer / С G. Moertel, D.S. Jr Childs, R.J. Reitemeier [et al. ] // Lancet. - 1969. - Vol. 2. - R 865-867.
60. Combined modality therapy for stage II and stage III pancreatic carcinoma /AG. Kamthan, J.C. Morris, J. Dalton [et al. ] //J. Clin. Oncol. - 1997 - Vol. 15 - P 2920-2927.
61. Combined modality therapy increasing local control of pancreatic cancer / H.W. Bruckner, S. Kalnicki, J. Dalton [et al.] // Cancer Invest. - 1993.-N 11.-P. 241-246.
62. Comparison of EUS7TNB and EUS7FNA in EUS?Guided Puncture of Pancreatic Tumors / T. Itoi, F. Itokawa A Sofuni [et al.] // Endoscopy. - 2005. - Vol. 37. - P. 362-366.
63. Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. / M.J. Moore, J. Hamm, J. Dancey [et al.] //J. Clin. Oncol. - 2003. - Vol. 21. - P. 3296-3302.
64. Comparison of linear array endoscopic ultrasound and helical computed tomography for the staging of periampullary, malignancies / D.E. Rivadeneira M. Pochapin, S.R. Grobmyer [et al.] // Ann. Surg. Oncol. - 2003. - Vol. 10. - P. 890-897.
65. Complications of endoscopic retrograde cholangiopancreatography. Analysis of 300 consecutive cases / D.S. Zimmon, D.B. Falkenstein, C. Riccobono, B. Aaron //Gastroenterology. - 1975. - N 69. - P. 303-309.
66. Computed tomography and laparoscopy in the assessment of the patient with pancreatic cancer / S.A Andren, C.G. Lindberg, C. Lundstedt [etal.] //J. Am. Coll. Surg. - 1998.-Vol. 186. - P. 35-40.
67. Conlon K.C. The value of laparoscopic staging in upper gastrointestinal malignancy / K.C. Conlon, E.A Minnard // Oncologist. - 1997. - Vol. 2. - P. 10-17.
68. Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer / М. Носке, E. Schulze, P. Gottschalk [et al. ] // World J. Gastroenterol. - 2006. -Vol. 12. - P. 246-250.
69. Contrast-enhanced ultrasonography of the pancreas / M. D'Onofrio, E. Martone, R. Malago [et al. ] // J. Pancreas (Online). - 2007 - Vol. 8 - P. 71-76.
70. Correlation of CT enhancement, tumor angiogenesis and pathologic grading of pancreatic carcinoma/Z.Q. Wang, J.S. Li.G.M. Lu [etal.] //World J. Gastroenterol. - 2003. - Vol. 9, N 9. - R 2100-2104.
71. Cotton P.B. Cannulation of the papilla of Vater by endoscopy and retrograde cholangiopancreatography (ERCP) / P.B. Cotton // Gut. -1972. - Vol. 13. - P. 1014-1025.
72. CT of the pancreas with a fatdensity oral contrast regimen /V. Raptopoulos, A Davidoff. A Karellas [et al. ] //Am J. Roentgenol. - 1988.-Vol. 150.-P 1303-1306
73. Cumulative meta-analysis of randomized trials comparing gemcitabine-based chemotherapy versus gemcitabine alone in patients with advanced or metastatic pancreatic cancer (PC) / E. Banu, S. Oudard. A Banu [et al.] //J. Clin. Oncol. - 2005. - N 23. - P. 4101.
74. Cuschieri A Laparoscopy for pancreatic cancer: does it benefit the patient? / A Cuschieri // Eur. J, Surg. Oncol. - 1988. - Vol. 14. -P. 41-44
75. Davis J.L. Septic complications following endoscopic retrograde cholangiopancreatography / J.L. Davis, F.D, Milligan, J.L. Cameron //Surg. Gynecol Obstet. - 1975. - Vol. 140. - P. 365-367.
76. Defining a role for endoscopic ultrasound in staging periampullary tumors/M. Shoup. P. Hodul, G.V. Aranha [etal.]//Am. J. Surg. - 2000. -Vol. 179. N6 P. 453-456.
77. Diagnosis and staging of pancreatic cancer by endoscopic ultrasound / K. Akahoshi, Y. Chijiiwa I Nakano [et al.] // Br J. Radiol. -1998 - N 71. - P 492-496
78. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations / H. Uehara A Nakaizumi, M. Tatsuta [et al. ] // Vestn Khir Im. Grek. - 1999. -Vol. 158, N. 3. - P. 21-25.
79. Diagnostic yield of endoscopic retrograde cholangiopancreatography in carcinoma of the pancreas/N.H. Gilinsky, P.C. Bornman, AH. Girdwood, I.N. Marks//Br. J. Surg. - 1986. -N 73. - P. 539-543.
80. Differential diagnosis of focal pancreatitis and pancreatic cancer /Т.М. VanGulik,T.M. Moojen, R. vanGeenen [etal.]//Ann. Ital. Chir. -1999. - N 70, Vol. 2. - P. 217-222.
81. Dobelbower R.R. Jr. The radiotherapy of pancreatic cancer /Dobelbower R.R. Jr. //Semin. Oncol. - 1979. - Vol. 6. - P. 378-389.
82. Effect of preoperative biliary decompression on pancreaticoduodenectomyassociated morbidity in 300 consecutive patients / PW. Pisters, W.A Hudec, K.R. Hess [et al.] // Ain. Surg. -2001. - Vol. 234, N 1. - P. 47-55.
83. Effect of preoperative biliary drainage on surgical outcome after pancreatoduodenectomy/ M.E. Martignoni, M. Wagner, L. Kpihenbbhl [et al.] //Am. J. Surg. - 2001. - Vol. 181, N 1. - P. 52-59.
84. Endoscopic ultrasonographic criteria of vascular invasion by potentially resectable pancreatic tumors / H. Snady, H. Bruckner, J. Siegel [et al.] // Gastrointest Endosc. - 1994. - Vol. 40. - P. 326-333.
85. Endoscopic ultrasonography (EUS) and Fine-Needle Aspiration (FNA) Cytology for diagnosis of chronic pancreatitis / S. Holerbach, A Klamann, T. Topalidis, W.H. Schmiegel // Endoscopy. - 2001. -Vol. 33, N10. -P. 824-831.
86. Endoscopic ultrasonography diagnosis of pancreatic cancer complicating chronic pancreatitis / M. Barthet, I. Portal, J. Boujaoude [et al.] // Endoscopy. - 1996. - Vol. 28. - P. 487-491.
87. Endoscopic ultrasound and fine needle aspiration in chronic pancreatitis: differential diagnosis between pseudotumoral masses and pancreatic cancer / J.C. Ardengh, C.V. Lopes, AD. Campos [et al.] //J. Pancreas (Online). - 2007. - Vol. 8, N 4. - P. 413-421.
88. Endoscopic ultrasound,criteria of vascular invasion in the staging of pancreatic head cancer/ a blind re-evaluation of videotapes / T. Rosch, H.J. Dittler, K. Strobel [et al.] //Gastrointest Endosc. - 2000. - Vol. 52. - P. 469-477.
89. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications/М. A Eloubeidi, V.K. Chen, I.A Eltoum [et al.] // Am. J. Gastroenterol. - 2003. - Vol. 98. - P. 2663-2668.
90. Endosonographic features predictive of lymph nodes metastasis / M.F. Catalano, M.V. Sivak, T. Rice [et al.] // Gastrointest endosc. -1994. - Vol. 40. - P 442-446.
91. Enlarged lymph nodes: Malignant or not?/Н. Grimm, K. Hamper, K.F. Binmoeller, N. Soehendra // Endoscopy. - 1992. - Vol. 24, Suppl 1. - P. 320.
92. EUS in preoperative staging of pancreatic cancer / N.A Ahmad, J.D. Lewis, G.G. Ginsberg [et al.] // Gastrointest Endosc. - 2000. -N 52. - P. 463-468.
93. EUS-guided photodynamic therapy of the pancreas: a pilot study / H.H. Chan, N.S. Nishioka M. Mino [et al.] // Gastrointest Endosc. - 2004.-Vol. 59.-P. 95-99.
94. EUS-guided radiofrequency ablation in the pancreas: results in a porcine model /S.N. Goldberg, S. Mallery, G.S. Gazelle, W.R. Brugge // Gastrointest. Endosc. - 1999. - Vol. 50. - P. 392-401.
95. Evaluation of pancreatic disease by endoscopic ultrasonography / S.M. Tenner, PA Banks, M.J. Wiersema J. van Dam // American Journal of Gastroenterology. - 1997. - Vol. 1. - P. 92.
96. Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas / G. Benassai, M. Mastrorilli, G. Quarto [et al.] // J. Surg. Oncol. - 2000. - Vol. 73. P. 212-218.
97. Factors predicting recurrence after resection of pancreatic ductal carcinoma / K. Shibata T. Matsumoto, K. Yada [et al.] // Pancreas. - 2005.-Vol. 31-P 69-73.
98. Fazel A Interventional endoscopic ultrasound in pancreatic disease/A Fazel, P. Draganov//Curr. Gastroenterol. Rep. - 2004. -Vol. 6.-P. 104-110.
99. Fogel E.L.Howtoimprovetheaccuracyofdiagnosisofmalignant biliary strictures / E.L. Fogel, S. Sherman // Endoscopy. - 1999. -Vol. 31.-P. 758-760.
100. Fortner J.G. Regional resection of cancer of the pancreas: a new surgical approach / J.G. Fortner// Surgery. - 1973. - N 73. - P 307-320.
101. Frank B.B. Clinical evaluation of Jaundice: a guideline of the patient care committee of the American Gastroenterological Association / B.B. Frank//Jama - 1989. - N 262. - P. 3031-3034.
102. Freeny P.C. Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography / PC. Freeny, L.W. Traverso, J.A Ryan // Am. J. Surg. - 1993. - Vol. 165. - P. 600-606.
103. Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial /С. Louvet, R. Labianca P. Hammel [etat] //J. Clin. Oncol. - 2005. - Vol. 23. - P. 3509-3516.
104. Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial / M. Reni, S. Cordio, C. Milandri [et al.] // Lancet Oncol. - 2005. - Vol. 6. - P. 369-376.
105. Habr F. Role of endoscopic ultrasound in the diagnosis and staging of pancreatic cancer / F. Habr, P. Akerman // Frontiers in Bioscienpe. - 2000. - Vol. 1, N 5. - P. 493-498.
106. Hawes R.H. Endosonography / R.H. Hawes, P. Fockens // Elsevier Inc. - 2006. - 329 p.
107. Helical computed tomography in the diagnosis of portal vein invasion by pancreatic head carcinoma: usefulness for selecting surgical procedures and predicting the outcome / H. Furukawa T. Kosuge, K. Mukai [etal ] //Arch. Surg. - 1998. - N 1, Vol. 133. - P. 61-65.
108. Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis / G. Kluppel. G. Lingenthal, M. von Bblow, H.F. Kern // Histopathology. - 1985 - Vol. 9. -P. 841-856.
109. Histological typing of tumours of the exocrine pancreas / G. Kluppel, E. Solcia D.S. Longnecker [et al.] // Organization WH. Ed.International Histological Classification of Tumours: 2n<J ed. - Berlin: Springer-Verlag, 1996.
110. Huntington D.K. Biliary tract dilatation in chronic pancreatitis: CT and sonographic findings / D.K. Huntington, M.C. Hill, W. Steinberg // Radiology. - 1989. - Vol. 172. - P. 47-50.
111. Identification and staging of pancreatic tumor using computed tomography, endoscopic ultrasound and magnafodipir trisodium-enhanced magnetic resonance imaging / D. Ramsay, M. Marschall, S. Song [et al.]//Aistralas radiol. - 2004. - Vol. 48 -P. 154-161.
112. Imaging of pancreatic neoplasms: comparison of MR and CT /Е. Steiner, D.D. Stark, P.F. Hahn [etal.] //Am. J. Roentgenol. - 1989. - N 152. - P. 487-491.
113. Inflammatory mass in the head of the pancreas / H G. Beger, W. Schlosser, B. Poch, F. Gansauge//The Pancreas: Eds. H.G. Beger. AL. Warshaw, M.W. Bbchler et al. - Oxford: Blackwell Science, 1998. P. 757-760
114. Intraoperative radiation therapy ad|uvant to resection in the treatment of pancreatic cancer / A Zerbi, V. Fossati, D. Parolmi [et al. ] //Cancer. - 1994. - Vol. 73. - P. 2930-2935.
115. Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate / C.M. Rocha Lima M.R. Green, R. Rotche [et al.] //J. Clin. Oncol. - 2004. - Vol. 22. - P. 3776-3783.
116. Ishida H. Peritoneoscopy and pancreas biopsy in the diagnosis of pancreatic diseases / H. Ishida // Gastrointest Endosc. - 1983. -Vol. 29. - P. 211-218.
117. Kalsen M.H. Pancreatic cancer-assessment of prognosis by clinical presentation / M.H. Kalsen, J.M. MacIntyre, J. Barkin // Castr. - 1983.-N84.-P. 1202.
118. Kida M. Endoscopic ultrasonography in Japan: present status and standardization / M. Kida // Digestive Endoscopy. - 2002. -14Suppl.-P. 22-29.
119. Klinkenbijl J.H. Adjuvant radiotherapy and 5fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group / J.H. Klinkenbijl, J. Jeekel, T. Sahmoud //Ain. Surg. - 1999. -Vol. 230, N 6. - P. 776-782.
120. K-ras mutations in duodenal aspirate without secretin stimulation for screening of pancreatic and biliary tract carcinoma / H. Watanabe, A Ha V.X. Hu [et al.] // Eur Radiol. - 1999. - Vol. 9, N 8. - P. 15131522.
121. Krinsky M.L. EUS-guided investigational therapy for pancreatic cancer / M.L. Krinsky, K.F. Binmoeller // Gastrointest Endosc. - 2000. - Vol. 52, 6 Suppl. - P. 35-38.
122. Kwon A.H. Preoperative laparoscopic examination using surgical manipulation and ultrasonography for pancreatic lesions / AH. Kwon, H. Inui, Y. Kamiyama // Endoscopy. - 2002. - Vol. 34. - P 464-468.
123. Laparoscopic pancreaticoduodenectomy for ductal adenocarcinoma of common bile duct: a case report and literature review / M.H. Zheng, B. Feng, AG. Lu [et al.] // Med. Scien. Monit. - 2006.-Vol. 12, N6.- P 57-60.
124. Laparoscopy and laparoscopic ultrasonography for staging pancreatic cancer: critical appraisal / A Pietrabissa D. Caramella G. DiCandio [et al. ]//World J. Surg. - 1999. - Vol. 23. - P. 998-1002.
125. Laparoscopyinthestagingofpancreaticcancer/RW Pisters, J.E. Lee, J.N. Vauthey [et al. ] // Br. J. Surg. - 2001. - Vol. 88. - P. 325-337.
126. Levy M.J. Chronic pancreatitis: Focal panreatitis or cancer? Is there a role for FNA/biopsy? Aitoimmune pancreatitis /M.J. Levy, M. J. Wiersema S.T. Chari // Endoscopy - 2006. - Vol. 38, S 1. - P 30-35.
127. Levy M.J. EUS-guided celiac plexus neurolysis and celiac plexus block / M.J. Levy, M.J. Wiersema // Gastrointest Endosc. - 2003. -Vol. 57. - P. 923-930.
128. Lim J.E. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients/J.E. Lim, M.W. Chien, C.C. Earle//Ain. Surg. -2003. -N237.-P. 74-85.
129. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA/C. Micames, PS. Jowell, R. White [etal.]//Gastrointest Endosc. - 2003. - Vol. 58. - P. 690-695.
130. Malcynski J.T, Severe Pancreatitis: Determinants of mortality in a tertiary referral center / J.T. Malcynski, I.e. Iwanow, K.W. Burchard //Arch. Surg - 1996. Vol. 131, N 3. - P. 242-246.
131. Manabe T. Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas / T. Manabe, G. Ohshio, N. Baba [et al.] //Cancer. - 1989. - N 64. - R 1132-1137.
132. «Massforming» pancreatitis masquerades as pancreatic carcinoma / K. Yamaguchi, K. Chijiiwa, S. Saiki [et al.] // Int. J. Pancreatol 1996. - Vol. 20, N 1 P. 27-35.
133. Mass-forming pancreatitis: value of contrast-enhanced ultrasonography/M. D'Onofrio, G.Zamboni, ATognolini [etal.]//World J. Gastroenterol. - 2006. - Vol. 12. - P. 4181-4184.
134. McFadden D.W. Cancer of the pancreas: radical resectionsupporting view/ D.W. McFadden, H.A Reber//Adv. Surg. -1994.-N27.-P. 257-272.
135. Menges M. The double duct sign in patients with malignant and benign pancreatic lesions / M. Menges, M.M. Lerch, M. Zeitz // Gastrointest Endosc. - 2000. - N 52. - P. 74-77.
136. Merchant N.B. Laparoscopic evaluation in pancreatic cancer /N.B. Merchant, K.C. Conlon //Semin. Surg. Oncol. - 1998. - Vol. 15. - P. 155-165.
137. Multi-detector row helical ct of the pancreas: effect of contrastenhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma / N.J. McNulty, I.R. Francis, J.F. Platt [et al.] // Radiology. - 2001. -Vol. 220. - P. 971-1002.
138. Nagai H. Lymphatic and Local Spread of T1 and T2 Pancreatic cancer. A study of autopsy material / H. Nagai, A Kuroda Y. Morioka //Ain. Surg. - 1986. - Vol. 204. - P. 65-71.
139. Norton K.S. Body and distal pancreatectomy for metastatic renal cell carcinoma: case report and review of the literature / K.S. Norton, G.B. Zibari // J. La State Med Soc. - 2004. - N 1. - P. 40-41.
140. Observations on the developmental patterns and the consequences of pancreatic exocrine adenocarcinoma Findings of 154 autopsies/C. Mao, D.R. Domenico, K. Kim fetal.] //ArchSurg. - 1995. - N 130. - P. 125-134.
141. Outcome following pancreaticoduodenectomy in patients undergoing preoperative biliary drainage / S. Srivastava S.S. Sikora A Kumar [et al.] // Dig. Surg. - 2001. - Vol. 18, N 5. - P. 381-387.
142. Pancreatectomies: Laparoscopic Approach / M. Del Chiaro, C. Croce, C. Moretto [et al.] // J. Pancreas (Online). - 2006. - Vol. 7, 5 Suppl. - P. 518-577.
143. Pancreaticcancer-isanaggressiveapproachjustified?/J.Krysa M. Miller, N. Kukreja, A Steger // Annals of The Royal College of Surgeons of England. 2005. - Vol. 87, N 3. - P 163 166.
144. Pancreatic carcinoma Diagnostic and prognostic implications of a normal pancreatogram / P.M. Hewitt, S.J. Beningfield, PC. Bornman [et al. ] // Surg. Endosc. - 1998. - Vol. 12. - P. 867-869.
145. Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus Dynamic MR imaging/T. Ishikawa H. Haradome, J. Hachiya [et al.] // Radiology. 1997. - N 202. - P. 655-662.
146. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma part 2: randomized controlled trial evaluating survival, morbidity, and mortality/C.J. Yeo, J.L. Cameron, K.D. Lillemoe [et al. ] // Ain. Surg. 2002 N 236. - P. 355-366.
147. Pancreatitis and the risk of cancer / AB. Lowenfels, P. Maisonneuve, G. Cavallini [etal.]//N. Engl. J. Med. - 1993. - N 328. - P. 1433-1437.
148. Percutaneous biopsy of periarterial soft tissue cuffs in the diagnosis of pancreatic carcinoma / M.J. O'Connell, E.K. Paulson, T.A Jaffe [et al. ] // Abdom Imaging. - 2004. - Vol. 29. N 1. - P. 1159.
149. Perineural invasion of carcinoma of the pancreas and biliary tract /Т. Nagakawa K. Mori, T. Nakano [et al. ] // Br. J. Surg. - 1993. - N 80. - P. 619-621.
150. Perioperative staging and the Munster TNM classification in ampullary and pancreatic cancer / M. Clemens, J. Meyer, U. Sulkowski [et al.] // Langenbecks Arch. Chir. - 1985. - Vol. 365, N 3. - R 169-178.
151. Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma / K.J. Chang, P.T. Nguyen, J.A Thompson [et al.] // Cancer. - 2000. - N 88. -P. 1325-1335
152. Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer / C.J. McGinn, M.M. Zalupski, I. Shureiqi [et al.] // J. Clin. Oncol. - 2001. - Vol. 19. - P. 4202-4208.
153. Phase III trial of gemcitabine (30-minute infusion) versus gemcitabine (fixed-dose-rate infusion [FDR]) versus gemcitabine + oxaliplatin (GEMOX) in patients with advanced pancreatic cancer (E6201)/ E. Poplin, D.E. Levy, J. Berlin [et al.] //J. Clin. Oncol. -2006. -Vol. 24, 18 S. -P. 4004.
154. Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer / E. Van Cutsem, H. vandeVelde, P Karasek[etal.]//J. Clin. Oncol. - 2004. -Vol. 22.-P. 1430-1438.
155. Photodynamic therapy for cancer of the pancreas / S.G. Bown, AZ. Rogowska D.E. Whitelaw [et al.] // Gut. - 2002. - N 50. - P. 549557.
156. Prediction of resectability of pancreatic malignancy by computed tomography / M.J. McCarthy, J. Evans, G. Sagar [et al.] // Br. J. Surg. - 1998.-Vol. 85.-P. 320-325.
157. Preoperative biliary drainage, colonisation of bile and postoperative complications in patients with tumours of the pancreatic head: a retrospective analysis of 241 consecutive patients / T.M. Karsten, J.H. Allema M. Reinders [etal ] // Eur. J. Surg. - 1996. -Vol. 162, N 11. - P. 881-888.
158. Preoperative endoscopic drainage for malignant obstructive jaundice/E.C. Lai, F.P. Mok, S.T. Fan S.T. [etal.] // Br. J. Surg. - 1994. -Vol. 81, N8.-P. 1195-1198.
159. Preoperative imaging of pancreatic cancer: a management-oriented approach/D.L. Clarke, S.R. Thomson,IE. Madiba C. Sanyika //J. Am. Coll. Surg. - 2003. - N 196, - P. 119-129.
160. Preoperative staging and assessment of resectability of pancreatic cancer/AL. Warshaw, Z.Y. Gu, J. Wittenberg, AC. Waltman //Arch. Surg. - 1990. - N 125. - P. 230-233.
161. Preoperative staging and tumor resectability of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography /F. Soriano, A Castells, C. Ayuso[etal.]//Am. J. Gastroenterol. -2004. -N99.-P. 492-501.
162. Primurdiagnostik und Stadiencinteilung des Pankreaskarzinoms Wertigkeit und Ajssagekraft von ERCP, Sonographic, Computertomographic und Aigiographic / R. Klapdor, B. Grabbe, J. Hagemann [etal.]//Munch. Med. Wschr. - 1980. - Vol. 122, N 10. - P. 343-344.
163. Prognostic factors after surgical resection for pancreatic carcinoma/P. Magistrelli, A Aitinori, A Crucitti [etal.]//J. Surg. Oncol. - 2000. - N 74. - P. 36-40.
164. Prolongation of the disease-free interval in surgically treated rectal carcinoma / Gastrointestinal Tumor Study Group // Engl. J. Med. - 1985 -N312.-P. 1465-1472.
165. Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography / B. Glasbrenner, M. Ardan, W. Boeck [et al.] // Endoscopy. - 1999. - N 31. - P 712-717.
166. Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in diagnostic of chronic pancreatitis / M.F. Catalano, S. Lahoti, J.E. Geenen [et al. ] //Gastrointest Endosc. - 1998 - N 48. - P. 11-17.
167. Prospective evaluation of EUS compared to ERCP and secretin stimulated pure pancreatic juice in the diagnosis of early chronic pancreatitis/M. Wiersema R. Hawes, G. Lehman [etal.]//Gastrointest Endosc. - 1992. - N 38. - P. 265.
168. Quality of life after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head / B. Schniewind, B. Bestmann, D. Henne-Bruns [etal.] // Br. J. Surg. - 2006. - P. 16.
169. Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine / T.S. Lawrence, E.Y. Chang, T.M. Hahn [et al.] // Int. J. Radiat. Oncol. Biol. Phys. - 1996. - N 34. - P 867-872.
170. Reappraisal of the clinical significance of tumor size in patients with pancreatic ductal carcinoma / K. Shimada Y. Sakamoto, T. Sano [et al.] // Pancreas. - 2006, - N 33. - P. 233-239.
171. Recurrent disease after microscopically radical (R0) resection of periampullary adenocarcinoma in patients without adjuvant therapy /S.M. De Castro, K.F. Kuhlmann, N.T. van Heek [etal.]//J Gastrointest Surg. - 2004. - Vol. 8. - P. 775-784.
172. Regional chemotherapy in the treatment of advanced pancreatic cancer - is it relevant? / M. Lorenz, S. Heinrich, E. StaibcSebler [et al.] // Europ. J. Cancer. - 2000. - Vol. 36. - P. 957-965.
173. Reni M. New T herapies for pancreatic cancer: Current standard / M. Reni, S. Cereda//J. Pancreas (Online). - 2007. - Vol. 8, 1 Suppl. -P. 98-101.
174. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators/T.A Sohn, C.J. Yeo, J.L. Cameron [et al.] //J. Gastrointest Surg. - 2000. - Vol. 4. - P. 567-579.
175. Resection of a solitary pancreatic metastasis from renal cell carcinoma with a gallbladder carcinoma: report of a case / H. Aidoh, T. Kurokawa O. Yasui, S. Shibata // Surg. Today. - 2004. - Vol. 34, N43. - P. 272-275.
176. RickesS. Contrast-enhanced ultrasound in the diagnosis of pancreatic tumors / S. Rickes, K. Monkemuller, P. Malfertheiner // J. Pancreas (Online). - 2006. - Vol. 7. - P. 584-592.
177. Role of EUS in the management of pancreatic and ampullary carcinoma: a prospective studyassessing resectability and prognosis / L. Buscail, P. Pages, P. Berthelemy [et al. ] // Gastrointest endosc. 1999. -N50. -P. 34-40.
178. Role of EUS in the preoperative staging of pancreatic cancer: a large sigle-center experience / F.G. Gress, R.H Hawes, T.J. Savides [et al. ] // Gastrointest endosc. - 1999 - N 50. - P 786-791
179. Rosai J. Ackerman's Surgical Patholody / J. Rosai. - St. Louis Toronto, Washington D.C., 1989. - Vol. 1. P 19- 22 Vol. 2 P 9231-9978.
180. Ryan D P Management of locally advanced adenocarcinoma of the pancreas / D.P. Ryan, C.G. Willett // Hematol. Oncol. Clin. North. Amer. - 2002. - Vol. 16. N 1. - P 95-103.
181. Safety and efficacy of TNFerade(TM) in unresectable, locally advanced pancreatic cancer (LAPC): Results of the first three cohorts of a dose-escalating study / N. Senzer, T. Chung, J R. Hecht [et al. ] //J. Clin. Oncol. - 2004. - N 22, 14S. P 3038.
182. Sarles H. Classification and definition of pancreatitis/Н. Sarles/ /Gastroenterol. Clin. Biol. - Marseilles Rome. 1988 - Vol. 13, N 11. - P. 857-859
183. Sarr M.G. Total pancreatectomy. Ai objective analysis of its use in pancreatic cancer / M.G. Sarr, K.E. Behrns. J A van Heerden // Hepatogastroenterology. - 1993. - Vol. 40, N 5. - P 418 421.
184. Schmulewitz N. EUS-guided celiac plexus neurolysis-technique and indication / N. Schmulewitz, R. Hawes // Endoscopy. 2003. N 35. - P. 49-53.
185. Schwarz R.E. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database / R.E. Schwarz, D.D. Smith //Ann. Surg. Oncol. - 2006. - Vol. 13. - P. 1189 1200.
186. Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature / N.V. Adsay, A Andea O. Basturk [et al.] // Virchows Arch. - 2004. - Vol. 444, N 6. - P. 527535.
187. Selective necrosis in hamster pancreatic tumours using photodynamic therapy with phthalocyanine photosensitization / P.T. Chatlani, PJ. Nuutinen, N. Toda [et al.] // Br. J. Surg. - 1992. -N 79. - P. 786-790.
188. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma / G. Benassai, M. Mastrorilli, F. Mosella G. Mosella//J. Exp. Clin. Cancer Res. - 1999. - N 18. - P 23-28,
189. Sindelar W.F Studies of intraoperative radiotherapy in carcinoma of the pancreas / W.F. Sindelar, T.J. Kinsella // Ann. Oncol. - 1999. -Vol. 10, Suppl 4. - P. 226-230.
190. Small pancreatic leasions: Is there need for EUS-FNA preoperatively? What to do with the incidental lesions? / H. Maguchi, K. Takahashi, M. Osanai, A Katanuma // Endoscopy. - 2006. - N 38, S 1,- P. 53-56.
191. Solcia E. Tumors of the pancreas /Е. Solcia C. Capella G. Kluppel // AFIP Atlas of Tumor Pathology: 3,d ed. - Washington DC: Armed Forces Institute of Pathology, 1997. - P 64.
192. Sonography of chronic pancreatitis /L. Bolondi, S. Li Bassi, S. Gaiani, L. Barbara // Radiol. Clin. North Am. - 1989. - N 27. - R 815-833.
193. Staging of ampullary and pancreatic carcinoma: comparison between endosonography and surgery/T.L. Tio, L.H. Sie, G. Kallimanis [et al.]//Gastrointestinal Endoscopy - 1996. - Vol. 44, N 6. - R 276-287.
194. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography/Т. Rosch, C. Braig, T. Gain [etal.] //Gastroenterology. - 1992. -N 102.-P. 188-199.
195. Standart imaging techniques in the pancreatobiliary region using radial scanning endoscopic ultrasonography / I. Kazuo, K. Misuhiro. F. Naotaka [et al. ] // Digestive Endoscopy. - 2004. - 16 Suppl. -R 118-133.
196. Surgical possibilities for pancreatic cancer: extended resection / , B. Kremer, I. Vogel, J. Luttges [et al] //Ann. Oncol. - 1999. - Vol. 10, Suppl 4 -P 252-256
197. The determinant factbrs of recurrence following resection for ductal pancreatic cancer/G. Barugola M. Falconi, R. Bettini [etal.]// J. Pancreas (Online). - 2007. - Vol. 8, 1 Suppl. - P. 132-140.
198. The diagnosis of pancreatic cancer by endoscopic ultrasonography / K. Yasuda H. Mukai, S. Fujimoto, M. Nakajima // Gastrointestinal Endosc. - 1998. - N 34. - P. 1-8.
199. The establishment of a preoperative diagnosis of pancreatic carcinoma using cell specimens from pancreatic duct brushing with special attention to p53 mutations / T. Iwao, K. Flanada A Tsuchida [et al. ] // Cancer 1998 N82 P 1487-1494.
200. The intensification of the radiotherapeutic effect on FleLa cells by gemcitabine / S. Mose. M. Karapetian, L. Juling-Pohlit [et al. ] // Strahlenther Onkol. - 1999. N 175. - P. 78-83.
201. The PACT trial: interim results of a randomized trial of TNFerade1" biologic plus chemoradiation (CRT) compared to CRT alone in locally advanced pancreatic cancer (LAPC) / N. Senzer, A Rosemurgy. M Javle [et al.] //J. Clin. Oncol. - 2006 - N24, 18S. - P 4102.
202. The use of EUS to diagnose malignant portal venous system invasion by pancreatic cancer / W.R. Brugge, M.J. Lee, P.B. Kelsey [et al. ]//Gastrointest Endosc 1996 N43 -P 561-567
203. The use of helical CT and CT angiography to predict vascular involvement from pancreatic cancer: correlation with findings at surgery /V. Raptopoulos, M.L. Steer, R.G. Sheiman [etal.]//Am. J. Roentgenol. - 1997.-Vol. 168.-P. 971-977.
204. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy / K.C. Conlon, E. Dougherty, D.S. Klimstra [et al.] // Ann. Surg. - 1996. - N 223. -P. 134-140.
205. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group / C.G. Moertel, S. Frytak, R.G. Flahn [et al.] // Cancer. - 1981. - N48. -P 1705-1710.
206. Total versus partial pancreatectomy in the surgical treatment of carcinoma of the pancreatic head / AM. Taschieri, M. Elli, M. Cristaldi [et al.] // Chir. Ital. - 1994. - Vol. 46, N 2. - P. 44-50.
207. Tretment and present status of Pancreatic cancer / H. Onoyama T. Kamigaki, M. Yamomoto, Y. Saitoh//Gan. To Kagaku. Ryoha - 1992. -Vol. 19, N 14.-P. 2304-2310.
208. Triple-tissue sampling at ERCP in malignant biliary obstruction / J. Jailwala E.L. Fogel, S. Sherman [et al.] // Gastrointest Endosc. - 2000.-N51.-P. 383-390.
209. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy / J.G. Fortner, D.S. Klimstra R.T. Senie [etal.]//Ann. Surg. - 1996.-N 223. - R 147-153.
210. Ultrasonic endoscope / E.R DiMagno, J.L. Buxton, P.T. Regan [etal.]//Lancet. - 1980. - N 22. - P. 629-631.
211. Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma / AC. Berger, I.M. Meszoel, E.A Ross [et al. ] // Ann. Surg. Oncol. - 2004. - Vol. 11- P. 644-649.
212. Using multidetector row computed tomography to diagnose and stage pancreatic carcinoma: the problems and the possibilities / M. Scaglione. A Pinto. S. Romano [et al. ] // J. Pancreas (Online). - 2005. -Vol. 13, N6. -P 1-5.
213. Vascular encasement by pancreatic cancer: correlation of CT findings with surgical and pathologic results/Y. Nakayama Y. Yamashita M Kadota [etal ] // J Comput. Assist. Tomogr. - 2001 - Vol. 25. N 3. - P. 337-342.
214. Warshaw AL. Laparoscopy in the staging and planning of therapy for pancreatic cancer / AL. Warshaw, J.E. Tepper, W.U. Shipley // Am. J Surg 1986 N151 P 76-80
215. Warshaw AL. Pancreatic carcinoma / AL. Warshaw, C.F. Castillo // N. Engl. J Med 1992. - N 326. - P 455-465.
216. Wilentz R.E. Screening for pancreatic cancer using techniques to detect altered gene products / R.E. Wilentz, R.J.C. Slebos, R H. Hruban//Pancreatic Cancer/Ed. H.A Reber. - 1998. - P 113-136.
217. Yasuda K. The handbook of endoscopic ultrasonography in digestive tract / K. Yasuda Blackwell Science Japa К. K., 2000. - 152 p
Рецензия
Для цитирования:
Неустроев В.Г. Очаговые образования поджелудочной железы. Клиническая эндоскопия. 2009;(2):29-45.
JATS XML

